Anti-TNFα Therapy and Mucosal Healing: The Key to Change the Pediatric Crohn's Disease Course?

被引：0
|
作者：
Nuti, Federica
Dilillo, Anna
Aloi, Marina
Di Nardo, Giovanni
Civitelli, Fortunata
Alessandri, Claudia
Oliva, Salvatore
Viola, Franca
Cucchiara, Salvatore
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S707 / S707
页数：1
相关论文
共 50 条
  • [41] Anti-TNFα Therapy in a Rare Case of Crohn's Disease: Still a Panacea
    Verburg, Robert
    Zelissen, Pierre
    Rothova, Aniki
    Siersema, Peter D.
    Oldenburg, Bas
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1457 - 1460
  • [42] Anti-TNF strategies in paediatric Crohn's disease
    Braegger, CP
    [J]. AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 153 - 158
  • [43] BIOLOGICAL THERAPY AND MUCOSAL HEALING IN A PEDIATRIC COHORT AFFECTED BY CROHN'S DISEASE
    Nuti, Federica
    Civitelli, Fortunata
    Di Nardo, Giovanni
    Bloise, Silvia
    Oliva, Salvatore
    Aloi, Marina
    Viola, Franca
    Cucchiara, Salvatore
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 : E89 - E89
  • [44] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S427 - S427
  • [45] Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease
    Verstockt, Bram
    Verstockt, Sare
    Creyns, Brecht
    Tops, Sophie
    Van Assche, Gert
    Gils, Ann
    Ceuppens, Jan L.
    Vermeire, Severine
    Ferrante, Marc
    Breynaert, Christine
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 572 - 581
  • [46] Adalimumab As First-Line Anti-TNF Treatment in Pediatric Crohn's Disease
    Martin-de-Carpi, Javier
    Navas-Lopez, Victor
    Navalon-Rubio, Maria
    Llerena-Santa-Cruz, Enrique
    Ortega, David Gil
    Varea-Calderon, Vicente
    Sierra-Salinas, Carlos
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S780 - S780
  • [47] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
  • [48] Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease
    Grand, RJ
    [J]. INFLAMMATORY BOWEL DISEASES, 2001, 7 (04) : 345 - 346
  • [49] Optimizing Immunomodulators and Anti-TNF Agents in the Therapy of Crohn Disease
    Dassopoulos, Themistocles
    Sninsky, Charles A.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 393 - +
  • [50] Anti-TNFα Therapy Alters the Natural History of Experimental Crohn's Disease When Begun Early, but Not Late, in the Disease Course
    Schmiedlin-Ren, Phyllissa
    Reingold, Laura J.
    Rittershaus, Ahren C.
    Brudi, Josh S.
    Adler, Jeremy
    McKenna, Barbara J.
    Zimmermann, Ellen
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S191 - S192
12345